Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00035360 | Phase III PEG-Intron in HIV-infected Patients (Study P00738) | PHASE3 | COMPLETED | 49 | — | — | Mar 1, 2002 | Oct 1, 2003 | Mar 10, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| PEG-Intron | DRUG | - |
Inclusion Criteria: * HIV positive * History of virologic failure on at least 2 antiretroviral regimens including exposure to at least one NRTI, one NNRTI and one PI * HIV RNA \>400-\<50,000 copies/mL * Laboratory parameters: platelet count (75,000u/L, hemoglobin \>9gm/dl, absolute neutrophil count...